Vericel (VCEL) Share-based Compensation (2010 - 2026)

Vericel (VCEL) reported Share-based Compensation of $11.3 million for Q1 2026, down 1.83% on a YoY basis from $11.5 million in Q1 2025, and up 269.89% sequentially from -$6.6 million in Q4 2025.

Vericel (VCEL) Share-based Compensation (2010 - 2026) Analysis & Trends

Vericel (VCEL) has 17 years of Share-based Compensation data on file, last reported at $11.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation fell 1.83% year-over-year to $11.3 million; the trailing twelve-month figure through Mar 2026 stood at -$211000.0 (down 102.13% YoY), and the FY2024 full-year result was $3.3 million, down 89.83% from the prior year.
  • Share-based Compensation advanced to $11.3 million in Q1 2026, from -$6.6 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $35.7 million in Q4 2022 to a low of -$25.3 million in Q4 2024.
  • A 5-year average of $4.9 million and a median of $4.9 million in 2024 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation tumbled 13362.3% in 2022 and jumped 29598.84% in 2024, its largest moves.
  • Tracing VCEL's Share-based Compensation over 5 years: stood at $35.7 million in 2022, then dropped by 15.79% to $30.1 million in 2023, then slumped by 184.13% to -$25.3 million in 2024, then jumped by 73.71% to -$6.6 million in 2025, then jumped by 269.89% to $11.3 million in 2026.
  • Business Quant data shows VCEL's Share-based Compensation at $11.3 million in Q1 2026, -$6.6 million in Q4 2025, and -$15.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn 11.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.29 Mn
Mar 31, 2026 11.29 Mn
Dec 31, 2025 -6.65 Mn
Dec 31, 2025 -6.65 Mn
Sep 30, 2025 -15.00 Mn
Sep 30, 2025 -15.00 Mn
Jun 30, 2025 10.14 Mn
Jun 30, 2025 10.14 Mn
Mar 31, 2025 11.51 Mn
Mar 31, 2025 11.51 Mn
Dec 31, 2024 -25.29 Mn
Dec 31, 2024 -25.29 Mn
Sep 30, 2024 25.54 Mn
Sep 30, 2024 25.54 Mn
Jun 30, 2024 -1.86 Mn
Jun 30, 2024 -1.86 Mn
Mar 31, 2024 4.90 Mn
Mar 31, 2024 4.90 Mn
Dec 31, 2023 30.06 Mn
Dec 31, 2023 30.06 Mn